Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
TRIER PHARM ApS
APS
Active
CVR 31611083
Tingskiftevej 6, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 17 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
TRIER PHARM ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
-35
32
61
-86
9
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-35
32
61
-86
9
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-35
32
61
-86
9
Net financials
-21
-23
-25
-30
-27
Profit before tax
-56
9
36
-116
-19
Tax
-0
-0
-0
-0
-0
Net profit
-56
9
36
-116
-19
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
444
508
259
278
170
Equity
-476
-467
-431
-547
-566
Long-term debt
0
0
0
0
0
Short-term debt
919
975
690
825
736
Total debt
919
975
690
825
736
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
100.0%
This company
2020
2024
Soliditetsgrad
-332.7%
This company
38.2%
Market median
-971% vs market
2020
2024
Egenkapitalforrentning
-1858200.0%
This company
18.4%
Market median
-10099013% vs market
2020
2024
Nettoresultatgrad (af bruttofortjeneste)
-214.9%
This company
2020
2024
Aktivomsætning (af bruttofortjeneste)
0.05×
This company
2020
2024
Gæld/egenkapital
1.30×
This company
0.62×
Market median
-110% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on TRIER PHARM ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
